Le Lézard
Classified in: Science and technology
Subjects: Dividend, Stock Sale/Buyback

CDW Authorizes $750 Million Share Repurchase Program Increase and Declares Quarterly Cash Dividend of $0.62 Per Share


CDW Corporation (Nasdaq: CDW), a leading multi-brand provider of information technology solutions to business, government, education and healthcare customers in the United States, the United Kingdom and Canada, today announced that its Board of Directors has authorized a $750 million increase to the company's share repurchase program and declared a quarterly cash dividend. The cash dividend of $0.62 per common share will be paid on March 12, 2024 to all stockholders of record as of the close of business on February 26, 2024. This amount represents a 5 percent increase over last year's dividend.

"Since our IPO in June 2013, our dividend has increased nearly fifteen-fold from its initial level and we have returned more than $6.3 billion to stockholders through dividends and share repurchases," said Albert J. Miralles, chief financial officer, CDW. "Our capital allocation strategy continues to emphasize dividend growth, along with managing our net leverage and making strategic acquisitions, in addition to share repurchases. This strategy has enabled us to deliver value to our stockholders just as we have delivered value to our customers and partners for 40 years."

Future dividends and share repurchase authorizations will be subject to approval by CDW's Board of Directors. The $750 million authorization is incremental to the approximately $338 million remaining from the previous repurchase program as of December 31, 2023. Share repurchases under the program will be made from time to time in private transactions, open market purchases or other transactions as permitted by securities laws and other legal requirements. The timing and amounts of any purchases will be based on market conditions and other factors including but not limited to price, regulatory requirements and capital availability. The program does not require the purchase of any minimum dollar amount or number of shares and the program may be modified, suspended or discontinued at any time.

About CDW

CDW Corporation (Nasdaq: CDW) is a leading multi-brand provider of information technology solutions to business, government, education and healthcare customers in the United States, the United Kingdom and Canada. A Fortune 500 company and member of the S&P 500 Index, CDW was founded in 1984 and employs approximately 15,100 coworkers. For the year ended December 31, 2023, CDW generated Net sales of approximately $21 billion. For more information about CDW, please visit www.CDW.com.

Forward-Looking Statements

Statements in this release that are not statements of historical fact are forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including without limitation statements regarding the future dividends, share repurchases, earnings growth, leverage ratio and other strategic plans of CDW. These forward-looking statements are subject to risks and uncertainties that may cause actual results or events to differ materially from those described in such statements. Although CDW believes that its plans, intentions and other expectations reflected in or suggested by such forward-looking statements are reasonable, it can give no assurance that it will achieve those plans, intentions or expectations. Reference is made to a more complete discussion of forward-looking statements and applicable risks contained under the captions "Forward-Looking Statements" and "Risk Factors" in CDW's Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent filings with the SEC. CDW undertakes no obligation to update or revise any of its forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law.

CDWPR-FI


These press releases may also interest you

at 07:35
Gossamer Bio, Inc. ("Gossamer") , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension, and Chiesi Farmaceutici S.p.A ("Chiesi Group"), an...

at 07:35
Tradeweb Markets Inc. , a leading, global operator of electronic marketplaces for rates, credit, equities and money markets, today reported total trading volume for the month of April 2024 of $41.9 trillion (tn)1. Average daily volume (ADV) for the...

at 07:35
Thryv Holdings, Inc. ("Thryv" or the "Company"), the provider of Thryv®, the leading small business software platform, announced today members of its management team will host 1:1 meetings at the following upcoming investor conferences:...

at 07:35
As part of EP Week, Alert Ready, Canada's national public alerting system, will be distributing a test alert to Canadians in participating provinces and territories on their television, radio and compatible wireless devices on Wednesday, May 8,...

at 07:34
From May 5 to 8, the China International Bicycle Exhibition opened grandly in Shanghai. TAILG, as a leading electric two-wheeler company, exhibited its latest full range of E-bike products. The on-site sales were booming, with visiting customers from...

at 07:30
Quipt Home Medical Corp. (the "Company") , a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal second quarter 2024 financial results on Wednesday, May 15, 2024. Gregory Crawford, Chief...



News published on and distributed by: